Authors
A founding member of TransCelerate BioPharma Inc. and a retired global clinical operations executive. During his career, he led worldwide clinical trial operations at Merck and held senior leadership roles at Sanofi, Genzyme, and Pfizer. He helped shape TransCelerate’s early strategy, governance, and project portfolio and served on its board as treasurer.
Emily Schoenthaler is a content producer for BioPharm International.
She is a senior director in data science and advanced analytics at IQVIA, where she leads a team developing predictive analytics with AI/ML, projections, precision targeting, and advanced statistical modeling. With over 25 years of pharmaceutical industry experience, Zhoi specializes in translating patient-level data into actionable business insights through custom analytical solutions that integrate multiple data sources.
Prior to IQVIA, she held progressive leadership positions at NDC Health, Verispan, and SDI. Zhou holds a master of science in industrial engineering from the University of Alabama and a bachelor of material management from Northern Jiaotong University in Beijing, China.
CEO and board member of Consano Bio. He previously led IMV Inc., a clinical-stage biopharmaceutical company in oncology that was acquired in 2023. Before IMV, Andrew spent 7 years at Celgene, where he led corporate development and pipeline strategy for immunology, as well as business development and strategic alliances, working on deals from discovery to commercialization.
Andrew also spent more than 15 years at Merck, BMS, and Schering Plough in leadership roles across Asia Pacific, Europe and the US.
Consultant, Shabas Solutions LLC
Founder and CEO of NAYA Therapeutics.
Brings more than 22 years of experience in leadership and operational roles across pharmaceutical, healthcare, financial services and automotive industries. As director of New Product Development at IQVIA, he leads product development within Global Market Insights, driving development and commercialization of GenAI solutions while also transforming the flagship IQVIA MIDAS® offering for global pharmaceutical market measurement. His expertise spans end-to-end client engagement management, business development and solution design for complex business challenges across Fortune 500 customers in the U.S., U.K., Europe and APAC regions.
VP, U.S. Thought Leadership & Innovation, IQVIA
Mitja Alexander Linss is the Head of Marketing for Karger Publishers
Rathi Suresh, PhD, is Vice President of Analytics at Komodo Health.
Senior director, video and digital content strategy, within global medical and Evidence at Bayer. His doctoral research examined how health information travelled across mainstream and social media during the COVID-19 pandemic. He is also a co-founder of The Undoctored Truths Alliance — a voluntary, volunteer-led initiative connecting a globally distributed network of trusted professionals (clinicians, scientists, communicators and patient advocates) to counter health misinformation. He writes in a personal capacity; the views expressed are his own.
Yamini Misra, MBA is the Vice President, Management Consulting Practice, AESARA Inc.
Managing Partner, Litmys
Senior Manager at Simon-Kucher, Seoul
Consultant, New York, with Simon-Kucher & Partners’ life sciences division
Partner at Simon-Kucher, New York.
President, Shabas Solutions LLC
Is a principal in IQVIA global launch excellence. He has 15 years of experience in life sciences, advising clients in all major geographies on launch excellence, go-to-market design, brand and commercial strategy, and omnichannel customer engagement.
Founder and CEO, Safeguard Global
Sarah Bandy, PharmD, PhD is a Manager, Value Evidence, AESARA Inc.